Skip to content

Serb Sustainability Reports

SERB is a global specialty pharmaceutical company focused on prescription medicines that address rare and life-threatening conditions. The company establishes and manages a direct portfolio of niche drugs and critical care medicines globally.

Sector: Manufacturing

Country: France

Exchange: Unlisted

LEI: 969500SODSBHSC9OC634

4 reports from 2023 to 2025